e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 4, 2011
 
SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION
 
(Exact name of registrant as specified in its charter)
         
Delaware   001-34465   20-1764048
Delaware   001-31441   23-2872718
(State or other jurisdiction of   (Commission File Number)   (I.R.S. Employer
Incorporation)       Identification No.)
 
4714 Gettysburg Road, P.O. Box 2034
Mechanicsburg, PA 17055

(Address of principal executive offices) (Zip Code)
(717) 972-1100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
o
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
   
o
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
   
o
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
   
o
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 


 

Item 2.02  
Results of Operations and Financial Condition
On August 4, 2011, Select Medical Holdings Corporation issued a press release announcing its financial results for its second quarter and six months ended June 30, 2011. A copy of that press release and the attached financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
Item 9.01  
Financial Statements and Exhibits.
(d) Exhibits.
         
Exhibit Number   Description
       
 
  99.1    
Press Release, dated August 4, 2011, announcing financial results for the second quarter and six months ended June 30, 2011.

 

 


 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
             
    SELECT MEDICAL HOLDINGS CORPORATION    
    SELECT MEDICAL CORPORATION    
 
           
Date: August 5, 2011
  By:   /s/ Michael E. Tarvin
 
Michael E. Tarvin
   
 
      Executive Vice President,    
 
      General Counsel and Secretary    

 

 


 

EXHIBIT INDEX
         
Exhibit Number   Description
  99.1    
Press Release, dated August 4, 2011, announcing financial results for the second quarter and six months ended June 30, 2011.